| 标题 |
 WED-371 Imdusiran (AB-729) administered every 8 weeks in combination with 24 weeks of pegylated interferon alfa-2a in virally suppressed, HBeAg-negative subjects with chronic HBV infection leads to HBsAg loss in some subjects at end of IFN treatment |
| 网址 | |
| DOI | |
| 其它 |
期刊：Journal of Hepatology 作者：Man-Fung Yuen; Jeong Heo; Ronald G. Nahass; Grace Lai-Hung Wong; Tatiana Burda; et al 出版日期：2024-06-08 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
DW
极限001
aaaa
aaa
意肆
lx
xing_xing
aajhajkahna
maxiaole
CR7
KWang
invisight
乐空思
碧海蓝天
Mic
初景
优雅的从安
坚强冰枫
fantasy22
皖公网安备34019202002308
